OtherMar 30, 2026, 03:34 AM
Abbott Laboratories Announces Temporary Trading Suspension in Employee Benefit Plans Due to Administrative Changes
AI Summary
Abbott Laboratories announced a temporary suspension of trading in its employee benefit plans, the Abbott Laboratories Stock Retirement Plan (U.S. Plan) and the Abbott Laboratories Stock Retirement Plan (Puerto Rico), due to administrative changes including changing the recordkeeper, trustee, and custodian. During the blackout period, plan participants will be unable to engage in transactions involving their plan assets, including trading Abbott common shares, which could temporarily affect trading volume.
Key Highlights
- Blackout period expected to begin on December 24, 2025, and end during the week of January 11, 2026.
- Plan participants will be unable to make changes to contribution rates, direct investments, or obtain loans/withdrawals during the blackout period.
- Abbott sent a notice to its directors and executive officers informing them of the trading restrictions during the blackout period, pursuant to Section 306 of the Sarbanes-Oxley Act.
Price Impact
More from ABT